Heart Transplants
Study results from Kobe University, Medical Department in the area of heart transplants published
Published in Drug Law Weekly, October 13th, 2009
According to recent research published in the Journal of Thoracic and Cardiovascular Surgery, "The peroxisome proliferator-activated receptor gamma activator pioglitazone has recently been reported to possess pleiotropic cardioprotective and renoprotective actions. We hypothesized that pioglitazone would reduce a dose of the immunosuppressant cyclosporine after heart transplantation, resulting in beneficial protective effects for both cardiac allografts and recipient kidneys."
"Experiments were performed by using an allomismatched rat heterotopic heart transplantation model. Recipients were treated with cyclosporine with or without pioglitazone and were divided...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-10-13)
More Articles from Drug Law Weekly
- Alexza Pharmaceuticals, Inc.
Alexza to Raise $19.7 Million in Private Placement - Bionovo, Inc.
Bionovo Announces Pricing of Securities Offering - Biopharmaceuticals
Keryx Biopharmaceuticals, Inc. to Raise $20 Million in Registered Direct Offering - Center for Justice & Democracy
National Consumer Groups Announce Urgent New Ads Asking Congress to Oppose Medical Malpractice Limits - Clinical Trial Research
More Than 100 Organizations Support Bill to Boost Participation in Clinical Trials for Rare Diseases - Emergency Medicine
Stephen W. Borron, M.D., Named Medical Editor-In-Chief of ToxED - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
